1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DB95C835711FD6DC852583C9006956FA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/DB95C835711FD6DC852583C9006956FA!OpenDocument
18
19OpenDocument
2035.172.203.87
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Document Excerpt: Optimizing the Size and Improving the Impact of Oncology Field-Based Medical Teams in Major Global Markets: Thought Leader Engagement, Managing Field Activities & Productivity Levels

DB Image

ID: MD-653


Features:

10 Info Graphics

20 Data Graphics

200+ Metrics

5 Narratives


Pages/Slides: 4


Published: 2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here.

This excerpt includes research findings and metrics from document #5553 "Optimizing the Size and Improving the Impact of Oncology Field-Based Medical Teams in Major Global Markets: Thought Leader Engagement, Managing Field Activities and Productivity Levels."

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Chemical; Manufacturing; Consumer Products; Diagnostic; Medical Device


Companies Profiled:
AstraZeneca; Daiichi Sankyo; Eisai; EMD Serono; Merck; Genentech; GlaxoSmithKline ; Shire; Janssen; Ipsen; Astellas; Amgen; Bayer; Roche; Merck Serono

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.